The influence of stimulation and blockade of D 2-type dopaminergic receptors on behavioral processes in female rats during key phases of ovary cycle



Cite item

Full Text

Abstract

The present work was devoted to the comparative analysis of influence of chronic administration of D2-receptors agonist -quinperoie (0,1 mg/kg, i.p.) and D2-receptors antagonist - sulpiride (10,0 mg/kg, i.p.) for 14 days on learning/memory processes, anxiety-like and depressive-like behaviors in the adult female rats. Learning of these animals was assessed in different models: passive avoidance performance and Morris water maze. Model of depression in rats was carried out in Porsolt test. Anxiety level was assessed in the elevated plus maze. Chronic quinperoie administration to females resulted in the appearance of the passive avoidance performance in proestrous and estrous, as distinct from the control animals. Also, quinperoie improved spatial learning in proestrous and stimulated it in estrous in Morris water maze. Chronic sulpiride administration similarly impaired non-spatial and spatial learning in females during all phases of ovary cycle. It was established that chronic quinperoie administration rendered an anxiolytic action in females during diestrous, estrous and proestrous phases, but failed to modify depression-like behavior during ovary cycle. Sulpiride administration resulted in anxiogenic effect in all phases of ovary cycle in females. Also, it was noted definite modulation of depression-like behavior in connection of ovary cycle phases in rats treated with sulpiride; at moderate level of estrogens was prodepressive action while at reduced/enhanced levels of estrogen - antidepressant effect. It is suggested different extent of D2-receptors receptors involvement in the mechanisms of anxiety-depressive-like behavior at alterations of hormonal balance during ovary cycle. The results of the study suggest modulating role of D2-receptors in behavioral processes during ovary cycle in the adult female rats. Also, the data obtained indicate in a close interaction between ovary hormonal and dopaminergic systems of the brain in mechanisms of anxiety and depression.

Full Text

Restricted Access

About the authors

Yu O Fedotova

I. P. Pavlov Institute of Physiology, Russian Academy of Sciences, St. Petersburg

Email: julia.fedotova@mail.ru

N S Sapronov

I. P. Pavlov Institute of Physiology, Russian Academy of Sciences, St. Petersburg; Institute of Experimental Medicine, Russian Academy of Medical Sciences, St. Petersburg

References

  1. Буреш Я., Бурешова О., Хьюстон Дж.П. Методики и основные эксперименты по изучению мозга и поведения. М.: Высшая школа, 1991.
  2. Воронина Т.А., Середенин С.Б. Методические указания по изучению транквилизирующего (анксиолитического) действия фармакологических веществ // Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. М.: ИИА Ремедиум, 2000. С. 126-130.
  3. Киршенблат Я.Д. Практикум по эндокринологии. М.: Высшая школа, 1969.
  4. Пономарев Д.Б., Виноградова Е.П. Сравнительный анализ способности к обучению в водном тесте Морриса у крыс, различающихся по скорости выработки условного рефлекса активного избегания // Журн. высш. нерв. деят. 2000. Т. 50. № 6. С. 974-981.
  5. Сапронов Н.С., Федотова Ю.О. Гормоны гипоталамо-гипофизарно-овариальной системы и мозг. СПб.: Формиздат, 2009.
  6. Шабанов П.Д., Лебедев A.A., Мешеров Ш.К. Дофамин и подкрепляющие системы мозга. СПб.: Лань, 2002.
  7. Abeliovich A.R. Midbrain dopamine neuron differentiation: factors and fates // Develop. Biol. 2007. Vol. 304. P. 447-454.
  8. Dagger M.R., Dutertrc W., Smith C.L. SKJF-82958 is a subtype-selective estrogen receptor -alpha agonist that induces functional interactions between ER alpha and AP-1 // J. Biol. Chem. 2002. Vol. 277. P. 1669-1679.
  9. Diaz-Veliz G., Benavides M.S., Butron S., Dussaubat N. et al. Behavioral effects of dopamine agonists and antagonists: influence of estrous cycle, ovariectomy and estradiol replacement in rats // Pharmacol. Biochem. Behav. 1999. Vol. 62. P. 21-29.
  10. Guillin O., Laruelle M. Neurobiology of Dopamine in Schizophrenia U Cell. Sei. Rev. 2005. Vol. 2. P. 345-389.
  11. Lammers C.H., De Souza U., Qin Z.H., Lee S.H. et al. Regulation of striatal dopamine receptors by estrogen // Synapse. 1999. Vol. 34. P. 222-227.
  12. Markou A., Duka T., Prelevic G.M. Estrogens and brain function // Hormones. 2005. Vol. 4. P. 9-17.
  13. Nieoullon A. Dopamine and the regulation of cognition and attention // Prog. Neurobiol. 2002. Vol. 67. P. 53-83.
  14. Porsolt R.D.G., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensctive to antidepressant treatment // Eur. J. Pharmacol. 1978. Vol. 47. P. 379-391.
  15. Rapkin A.J., Winer S.A. The pharmacologic management of premenstrual dysphoric disorder // Exp. Opin. Pharmacol. 2008. Vol. 9. P. 429-445.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011 Fedotova Y.O., Sapronov N.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies